CTS CORP Stock Compensation Disclosure
NOTE 17 — Stock-Based Compensation
At December 31, 2025, we had five stock-based compensation plans: the Non-Employee Directors' Stock Retirement Plan ("Directors' Plan"), the 2004 Omnibus Long-Term Incentive Plan ("2004 Plan"), the 2009 Omnibus Equity and Performance Incentive Plan ("2009 Plan"), the 2014 Performance and Incentive Plan ("2014 Plan"), and the 2018 Equity and Incentive Compensation Plan ("2018 Plan"). Future grants can only be made under the 2018 Plan. The 2018 Plan allows for grants of stock options, stock appreciation rights, restricted stock, RSUs, performance shares, performance units, and other stock awards subject to the terms of the 2018 Plan.
The following table summarizes the compensation expense included in selling, general and administrative expenses in the Consolidated Statements of Earnings related to stock-based compensation plans:
|
|
Years Ended December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Service-Based RSUs |
|
$ |
3,120 |
|
|
$ |
3,788 |
|
|
$ |
2,869 |
|
Performance-Based RSUs |
|
|
1,234 |
|
|
|
1,673 |
|
|
|
1,813 |
|
Cash-settled awards |
|
|
535 |
|
|
|
189 |
|
|
|
499 |
|
Total |
|
$ |
4,889 |
|
|
$ |
5,650 |
|
|
$ |
5,181 |
|
Income tax benefit |
|
|
1,149 |
|
|
|
1,300 |
|
|
|
1,192 |
|
Net |
|
$ |
3,740 |
|
|
$ |
4,350 |
|
|
$ |
3,989 |
|
The fair value of all equity awards that vested during the periods ended December 31, 2025, 2024 and 2023 were $7,269, $7,599 and $8,282, respectively. We recorded a tax deduction related to equity awards that vested during the year ended December 31, 2025, in the amount of $1,566.
The following table summarizes the unrecognized compensation expense related to non-vested RSUs by type and the weighted-average period in which the expense is to be recognized:
|
|
Unrecognized |
|
|
Weighted- |
|
Service-Based RSUs |
|
$ |
2,796 |
|
|
1.24 |
Performance-Based RSUs |
|
|
2,901 |
|
|
1.80 |
Total |
|
$ |
5,697 |
|
|
1.52 |
We recognize expense on a straight-line basis over the requisite service period for each separately vesting portion of the award as if the award was, in substance, multiple awards.
The following table summarizes the status of these plans as of December 31, 2025:
|
|
2018 Plan |
|
|
2014 Plan |
|
|
2009 Plan |
|
|
2004 Plan |
|
|
Directors' Plan |
|
|||||
Awards originally available to be granted |
|
|
2,500,000 |
|
|
|
1,500,000 |
|
|
|
3,400,000 |
|
|
|
6,500,000 |
|
|
N/A |
|
|
Maximum potential awards outstanding |
|
|
701,842 |
|
|
|
35,100 |
|
|
|
30,000 |
|
|
|
14,545 |
|
|
|
4,722 |
|
RSUs and cash settled awards vested and |
|
|
780,474 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Awards available to be granted |
|
|
1,017,684 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Service-Based Restricted Stock Units
Service-based RSUs entitle the holder to receive one share of common stock for each unit when the unit vests. RSUs are issued to officers, key employees, and non-employee directors as compensation. Generally, the RSUs vest over a three-year period. RSUs granted to non-employee directors generally vest one year after being granted. Upon vesting, the non-employee directors may elect to either receive the stock associated with the RSU immediately or defer receipt of the stock to a future date. The fair value of the RSUs is equivalent to the trading value of our common stock on the grant date.
A summary of RSU activity for the year ended December 31, 2025 is presented below:
|
|
Units |
|
|
Weighted |
|
|
Weighted |
|
|
Aggregate |
|
||||
Outstanding at January 1, 2025 |
|
|
322,847 |
|
|
$ |
34.06 |
|
|
|
|
|
|
|
||
Granted |
|
|
96,208 |
|
|
|
44.46 |
|
|
|
|
|
|
|
||
Released |
|
|
(62,764 |
) |
|
|
40.58 |
|
|
|
|
|
|
|
||
Forfeited |
|
|
(35,651 |
) |
|
|
44.10 |
|
|
|
|
|
|
|
||
Outstanding at December 31, 2025 |
|
|
320,640 |
|
|
$ |
34.82 |
|
|
|
19.33 |
|
|
$ |
13,746 |
|
Releasable at December 31, 2025 |
|
|
169,267 |
|
|
$ |
26.42 |
|
|
|
28.99 |
|
|
$ |
7,256 |
|
|
|
Years Ended December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Weighted-average fair value upon release |
|
$ |
45.97 |
|
|
$ |
45.66 |
|
|
$ |
45.19 |
|
Intrinsic value of RSUs released |
|
$ |
2,885 |
|
|
$ |
2,682 |
|
|
$ |
3,316 |
|
A summary of non-vested RSU activity for the year ended December 31, 2025 is presented below:
|
|
RSUs |
|
|
Weighted |
|
||
Nonvested at January 1, 2025 |
|
|
160,780 |
|
|
$ |
44.07 |
|
Granted |
|
|
96,208 |
|
|
|
44.46 |
|
Vested |
|
|
(69,964 |
) |
|
|
44.43 |
|
Forfeited |
|
|
(35,651 |
) |
|
|
44.10 |
|
Nonvested at December 31, 2025 |
|
|
151,373 |
|
|
$ |
44.21 |
|
Performance-Based Restricted Stock Units
We grant performance-based restricted stock units ("PRSUs") to certain executives and key employees. PRSUs are usually awarded in the range from zero percent to 200% of a targeted number of shares. The award rate for the 2023-2025, 2024-2026 and 2025-2027 PRSUs is dependent upon our achievement of targets for sales growth, cash flow, and a relative total shareholder return ("RTSR") modifier. We use a matrix based on the percentile ranking of our stock price performance compared to a peer group of companies over a three-year period to calculate the achievement of the RTSR targets. Other PRSUs are granted from time to time based on other performance criteria. The initial fair value of the PRSUs is equivalent to the trading value of the target amount of our common stock on the grant date. The fair value is subsequently adjusted quarterly based on management's assessment of the Company's performance relative to the target number of shares performance criteria.
A summary of PRSU activity for the year ended December 31, 2025 is presented below:
|
|
Units |
|
|
Weighted |
|
|
Weighted |
|
|
Aggregate |
|
||||
Outstanding at January 1, 2025 |
|
|
222,344 |
|
|
$ |
40.15 |
|
|
|
|
|
|
|
||
Granted |
|
|
106,943 |
|
|
|
44.72 |
|
|
|
|
|
|
|
||
Added by performance factor |
|
|
39,581 |
|
|
|
37.93 |
|
|
|
|
|
|
|
||
Released |
|
|
(79,162 |
) |
|
|
37.93 |
|
|
|
|
|
|
|
||
Forfeited |
|
|
(89,108 |
) |
|
|
37.32 |
|
|
|
|
|
|
|
||
Outstanding at December 31, 2025 |
|
|
200,598 |
|
|
$ |
44.07 |
|
|
|
2.50 |
|
|
$ |
8,734,677 |
|
Releasable at December 31, 2025 |
|
|
— |
|
|
$ |
— |
|
|
|
|
|
$ |
— |
|
|
The following table summarizes each grant of PRSUs outstanding at December 31, 2025:
Description |
|
Grant Date |
|
Vesting Year |
|
Vesting Dependency |
|
Target Units |
|
|
Maximum Number |
|
||
2023-2025 Performance RSUs |
|
February 9, 2023 |
|
2025 |
|
60% sales growth, |
|
|
48,573 |
|
|
|
97,146 |
|
2024-2026 Performance RSUs |
|
February 7, 2024 |
|
2026 |
|
60% sales growth, |
|
|
59,403 |
|
|
|
118,806 |
|
2025-2027 Performance RSUs |
|
Varies |
|
2027 |
|
60% sales growth, |
|
|
69,637 |
|
|
|
139,274 |
|
Evolution 2030 Performance RSUs |
|
June 2, 2025 |
|
2028 |
|
70% sales target, |
|
|
9,204 |
|
|
|
18,408 |
|
Evolution 2030 Performance RSUs |
|
June 2, 2025 |
|
2030 |
|
70% sales target, |
|
|
13,781 |
|
|
|
27,562 |
|
Total |
|
|
|
|
|
|
|
|
200,598 |
|
|
|
401,196 |
|
Cash-Settled Restricted Stock Units
Cash-Settled RSUs entitle the holder to receive the cash equivalent of one share of common stock for each unit when the unit vests. These RSUs are issued to key employees residing in foreign locations as direct compensation. Generally, these RSUs vest over a three-year period. Cash-settled RSUs are classified as liabilities and are remeasured at each reporting date until settled. At December 31, 2025 and 2024, we had 39,661 and 44,127 cash-settled RSUs outstanding, respectively. At December 31, 2025 and 2024, liabilities of $594 and $608, respectively, were included in accrued expenses and other liabilities on our Consolidated Balance Sheets.
About Stock Compensation Disclosures
Stock-based compensation disclosures detail the equity awards granted to employees and executives — including stock options, restricted stock units (RSUs), and performance shares — along with the valuation methods and assumptions used to expense them. This section reveals the true cost of talent retention and the alignment between management incentives and shareholder interests.
Key signals: total unrecognized compensation expense and its expected recognition period signal future earnings headwinds from already-granted awards. For stock options, examine Black-Scholes assumptions — expected volatility, risk-free rate, and expected term — as understating any of these reduces reported compensation expense. Compare stock compensation expense as a percentage of revenue against peers to assess dilution cost. Watch vesting schedules for acceleration clauses tied to change-of-control events. Performance-based awards with undemanding targets may indicate weak governance. Add back stock compensation to operating cash flow to calculate a more conservative free cash flow figure.